Raising a seed round in biotech.
What seed investors expect from a biotech company, who writes checks at this stage, the terms you will see and the slides they read first.
Biotech
Biotech investors fund data, not traction. Each round buys the next experiment that removes a risk: a preclinical result, an IND, a clinical readout. Grants and licensing deals often matter as much as equity.
What seed investors expect in biotech
Seed in biotech funds the preclinical work that leads toward an IND. Show each of these on a slide of its own.
Preclinical proof
- Efficacy in a relevant disease model
- Early safety and dosing signals
- A lead candidate or a platform with a first target
A path to the clinic
- The studies an IND will need, in order
- Manufacturing partners for early material
- A timeline and budget to the IND filing
Strong IP and a clear indication
- Composition or method patents filed
- A first indication picked for speed and clear endpoints
- Why later indications make the asset bigger
How the round comes together
Investor types, not names. Read each guide, then match inside your account.
- 1 · A specialist fund leads
- 2 · Grants extend the runway
- 3 · Angels and strategics fill
Pre-seed & seed funds
Often leads
Life science seed funds lead most biotech seed rounds, often in tranches.
Grants & non-dilutive
Often follows
Later-phase research grants keep funding preclinical work beside equity.
University funds
Sometimes
University funds follow on for spinouts from their institution.
Corporate VCs
Sometimes
Pharma venture arms join early when the science fits their pipeline.
Angels
Now and then
Industry veterans add small checks and expertise.
Tranches tied to data
Biotech seed rounds are often priced and paid in tranches. Investors commit a total, then release money as you hit agreed scientific milestones. Make the milestones specific and within your control.
The slides investors read first
Data
Efficacy and safety in the best model you have.
Candidate
Lead asset or platform, and why it wins.
Path to IND
Studies, partners, timeline and cost.
IP
Patents filed and what they protect.
The ask
Amount, tranches and the milestones they unlock.
Questions founders ask
What is a tranched round?
Investors agree to a total amount but fund it in parts. Each part is released when you reach a milestone, such as a preclinical result. If you miss one, later money may not arrive.
Should I partner with pharma at seed?
A research collaboration can validate the science and bring cash. Watch for terms that give away rights to your lead asset too early.
Sources
Sources: FDA guidance on IND applications and clinical phases; federal research grant program guidance; university technology transfer practice; investors' published criteria. Editorial content, reviewed quarterly. Not financial, legal or medical advice.
Other stages
Related sectors
Who funds this round
Learn the terms
Run the numbers
Raise in your city
Inside Unicorn Factory
Free account
Investor matching is coming to your free account. Create it now and we will match your round the day it opens. Until then, get an honest read on your deck.